Generic placeholder image

The Natural Products Journal


ISSN (Print): 2210-3155
ISSN (Online): 2210-3163

Research Article

α-Glucosidase Inhibitory Activity of the Extracts and Major Phytochemical Components of Smilax glabra Roxb

Author(s): Phuong T.M. Nguyen*, Quang V. Ngo, Minh T.H. Nguyen, Alan T. Maccarone and Stephen G. Pyne*

Volume 10 , Issue 1 , 2020

Page: [26 - 32] Pages: 7

DOI: 10.2174/2210315509666190124111435

Price: $65


Background: A therapeutic approach to treat diabetes is to decrease postprandial hyperglycemia. α-Glucosidase inhibitors from plant sources offer an attractive strategy for the control of hyperglycemia. Smilax glabra Roxb is a medicinal plant found in Asia, including Vietnam, which is used in the treatment of chronic diseases. However, the antidiabetic activity and the identification of α-glucosidase inhibitors from this plant have not been intensively investigated. This research was carried out to determine the α-glucosidase inhibitory activity of the extracts and that of the major phytochemical components of Smilax glabra Roxb. This could lead to further studies on the role of these compounds in hyperglycemia control, as well as identify their potential future applications.

Methods: Column chromatography combined with crystallization procedures were used to isolate active fractions and two major compounds. The chemical structures of these compounds were determined by analysis of their NMR spectroscopic data, as well as MS data and comparisons made with the literature data. The α-glucosidase inhibitory activity was determined spectrophotometrically using p-nitrophenyl α-D-glucopyranoside as a substrate. The in vitro cytotoxicity of the isolated compounds and fractions was determined using the MTT assay.

Results: The two major compounds, astilbin and 5-O-caffeoylshikimic acid together with two very active fractions, F7 and F8, were isolated from the rhizome. The two major compounds had α- glucosidase inhibitory activities with IC50 values of ca. 125 µg/mL and 38 µg/mL, respectively which are about 4 and 13 folds higher activity than the reference compound acarbose (IC50 of ca. 525 µg/mL). Fractions F7 and F8 showed very promising inhibitory activities towards α-glucosidase with IC50 values of 5.5 and 5.8 µg/mL, respectively. Cytotoxicity data on mouse fibroblast NIH3T3 cells indicated that the active compounds and fractions were not toxic at concentrations that are greater than their respective IC50 values. The α-glucosidase inhibitory activity of 5-Ocaffeoylshikimic acid and that of the two active fractions are reported here for the first time.

Conclusion: The two major isolated compounds and fractions, F7 and F8, significantly contribute to the α-glucosidase inhibitory activity of S. glabra Roxb extract. Further work is needed to clarify their modes of action and potential application.

Keywords: Smilax glabra Roxb, astilbin, 5-O-caffeoylshikimic acid, α-glucosidase inhibitors, cytotoxicity, NMR, spectroscopic data.

Graphical Abstract
Global burden of diabetes. International diabetes federation. IDF Diabetes Atlas, 5th edition., Brussels, Belgium:. 2011, 5 Available at:
Kalra, S. Alpha glucosidase inhibitors. J. Pak. Med. Assoc., 2014, 64(4), 474-476.
Nishibori, N.; Sawaguchi, M.; Hiroi, T. Inhibitory effects of aqueous extract prepared from joint part of lotus root on α-amylase and α-glucosidase activities. Phytopharmacology, 2012, 3(1), 1-11.
Zhang, L.; Chen, Q.; Li, L.; Kwong, J.S.W.; Jia, P.; Zhao, P.; Wang, W.; Zhou, X.; Zhang, M.; Sun, X. Alpha-glucosidase inhibitors and hepatotoxicity in type 2 diabetes: A systematic review and meta-analysis. Sci. Rep., 2016, 6, 32649.
Kang, W. Alpha glucosidase inhibitory in vitro and antidiabetic activity in vivo of Osmanthus fragrans. J. Med. Plants Res., 2012, 6(14), 2850-2856.
Kumar, S.; Narwal, S.; Kumar, V.; Prakash, O. α-glucosidase inhibitors from plants: A natural approach to treat diabetes. Pharm. Rev., 2011, 5(9), 19-29.
Lin, C.; Yin, M.C. Renal protective effects of extracts from Guava fruit (Psidium guajava L.) in diabetic mice. Plant Foods for Hum. Nutr., 2012, 67(3), 303-308.
Johnson, O.O.; Zhao, M.; Gunn, J.; Santarsiero, B.D.; Yin, Z.Q.; Ayoola, G.A.; Coker, H.A.; Che, C.T. α-Glucosidase inhibitory prenylated anthranols from Harungana madagascariensis. J. Nat. Prod., 2016, 79(1), 224-229.
Kumar, S.; Pandey, A.K. Chemistry and biological activities of flavonoids: An overview. ScientificWorldJournal, 2013, (11-12)162750
Tunna, T.S.; Ahmed, Q.U.; Helal, A.B.M.; Zaidul, I.S.M. Weeds as alternative useful medicinal source: Mimosa pudica Linn. on diabetes mellitus and its complications. Adv. Mat. Res., 2014, 995, 45-59.
Tasnuva, S.T.; Qamar, U.A.; Ghafoor, K.; Sahena, F.; Jahurul, M.H.A.; Rukshana, A.H.; Juliana, M.J.; Al-Juhaimi, F.Y.; Jalifah, L.; Jalal, K.C.A.; Ali, M.E.; Zaidul, I.S.M. α-glucosidase inhibitors isolated from Mimosa pudica L. J. Nat. Prod., 2017, 27, 1-5.
Do-Tat, L. The medical plants and natural drugs in vietnam; Science and Technology Publishing House: Hanoi, 1991, pp. 498-499.
Nguyen, M.T.T.; Nguyen, H.X.; Huynh, T.N.N.; Min, B.S. Screening of α-glucosidase inhibitory activity of Vietnamese medicinal plants: Isolation of active principles from Oroxylum indicumin. Nat. Prod. Sci., 2012, 18(1), 47-51.
Liang, Y.; Xu, L.Y.; Kang, A.; Xie, Y.; Xie, T.; Liu, L.; Hao, H.; Xie, L.; Wang, G. Validation and application of an LC-ESI-MS method for simultaneous determination of astilbin and its major metabolite 3′- O-methylastilbin in rat plasma. J. Chrom. B., 2009, 877, 1765-1770.
Scudiero, D.A.; Shoemaker, R.H.; Paull, K.D.; Monks, A.; Tierney, S.; Nofziger, T.H.; Currens, M.J.; Seniff, D.; Boyd, M.R. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res., 1988, 48(17), 4827-4833.
Trinh, T.T.V.; Vu, V.C.; Pham, T.H.; Pham, V.C.; and Nguyen, Q.V. Antioxidant activity of extracts and astilbin from the root of Smilax glabra of Vietnam. Malaysian J. Chem., 2015, 17(1), 12-19.
Lu, C.L.; Zhu, Y.F.; Hu, M.M.; Wang, D.M.; Xu, X.J.; Lu, C.J.; Zhu, W. Optimization of astilbin extraction from the rhizome of Smilax glabra, and evaluation of its anti-inflammatory effect and probable underlying mechanism in lipopolysaccharide-induced RAW264.7 macrophages. Molecules, 2015, 20(1), 625-644.
Kasai, R.; Hirono, S.; Chou, W.; Tanaka, O.; Chen, F. Sweet dihydroflavonol rhamnoside from leaves of Engelhardtia chrysolepis, a Chinese folk medicine, Hung-qi. Pharm. Bull., 1988, 36, 4167-4170.
Fukuoka, M. Chemical and toxicological studies on Bracken Fern, Pteridium aquilinum Var. latiusculum VI. Isolation of 5-O-caffeoylshikimic acid as an antithiamine factor. Chem. Pharm. Bull. , 1982, 30(9), 3219-3224.
Xu, S.; Shang, M.Y.; Liu, G.X.; Xu, F.; Wang, X.; Shou, C.C.; and Cai, S.Q. Chemical constituents from the rhizomes of Smilax glabra and their antimicrobial activity. Molecules, 2013, 18, 5265-5287.
Pérez-Nájera, V.C.; Gutiérrez-Uribe, J.A.; Antunes-Ricardo, M.; Hidalgo-Figueroa, S.; Del-Toro-Sánchez, C.L.; Salazar-Olivo, L.A.; Lugo-Cervantes, E. Smilax aristolochiifolia root extract and its compounds chlorogenic acid and astilbin inhibit the activity of α-amylase and α-glucosidase enzymes. Evid. Based Complement. Alternat. Med., 2018, 2018(3), 1-12.

Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy